Stealth lipid polymer hybrid nanoparticles loaded with rutin for effective brain delivery – comparative study with the gold standard (Tween 80): optimization, characterization and biodistribution

References

• Abdel-Messih HA, Ishak RA, Geneidi AS, Mansour S. (2017). Nanoethosomes for transdermal delivery of tropisetron HCl: multi-factorial predictive modeling, characterization, and ex vivo skin permeation. Drug Dev Ind Pharm 43:958–71.
   PubMed Web of Science ®Google Scholar
• Agrawa LP, Singh R, Sonali, et al. (2017). TPGS-chitosan cross-linked targeted nanoparticles for effective brain cancer therapy. Mater Sci Eng C 74:167–76.
   PubMed Web of Science ®Google Scholar
• Agrawal U, Chashoo G, Sharma P, et al. (2015). Tailored polymer-lipid hybrid nanoparticles for the delivery of drug conjugate: dual strategy for brain targeting. Colloids Surf B Biointerfaces 126:414–25.
   PubMed Web of Science ®Google Scholar
• Ahmad H, Arya A, Agrawal S, et al. (2016). Rutin phospholipid complexes confer neuro-protection in ischemic-stroke rats. RSC Adv 6:96445–54.
   Web of Science ®Google Scholar
• Choi MH, Rho JK, Kang JA, et al. (2016). Efficient radiolabeling of rutin with 125I and biodistribution study of radiolabeled rutin. J Radioanal Nucl Chem 308:477–83.
   Web of Science ®Google Scholar
• Collnot E-M, Baldes C, Schaefer UF, et al. (2010). Vitamin E TPGS P-Glycoprotein inhibition mechanism: influence on conformational flexibility, intracellular ATP levels, and role of time and site of access. Mol Pharmaceutics 7:642–51.
   PubMed Web of Science ®Google Scholar
• Costa EMD, Filho JMB, Nascimento TGD, Mac do RO. (2002). Thermal characterization of the quercetin and rutin flavonoids. Thermochim Acta 392-393:79–84.
   Web of Science ®Google Scholar
• Derringer G. (1994). A balancing act: optimizing a product’s properties. Qual Prog 5:1–5.
   Google Scholar
• Dobrovolskaia MA, Clogston JD, Neun BW, et al. (2008). Method for analysis of nanoparticle hemolytic properties in vitro. Nano Lett 8:2180–7.
   PubMed Web of Science ®Google Scholar
• Durán-Lobato M, Muñoz-Rubio I, Holgado MÁ, et al. (2014). Enhanced cellular uptake and biodistribution of a synthetic cannabinoid loaded in surface-modified poly(lactic-co-glycolic acid) nanoparticles. J Biomed Nanotechnol 10:1–12.
   PubMed Web of Science ®Google Scholar
• Fathalla D, Soliman G, Fouad E. (2015). Development and in vitro/in vivo evaluation of liposomal gels for the sustained ocular delivery of latanoprost. J Clin Exp Ophthalmol 6:390. doi:10.4172/2155-9570.1000390.
   Google Scholar
• Fathiazada F, Delazara A, Amiria R, Sarker SD. (2006). Extraction of flavonoids and quantification of rutin from waste Tobacco leaves. Iran J Pharm Res 3:222–7.
   Google Scholar
• Gabal Y, Kamel A, Sammour O, Elshafeey A. (2014). Effect of surface charge on the brain delivery of nanostructured lipid carriers in situ gels via the nasal route. Int J Pharm 473:442–57.
   PubMed Web of Science ®Google Scholar
• Gao Z, Xu H, Huang K. (2002). Effects of rutin supplementation on antioxidant status and iron, copper, and zinc contents in mouse liver and brain. Biol Trace Elem Res88:271–9.
   PubMed Web of Science ®Google Scholar
• Gessner A, Olbrich C, Schroeder W, et al. (2000). The role of plasma proteins in brain targeting: Species dependent protein adsorption patterns on brain-specific lipid drug conjugate (LDC) nanoparticles. Int J Pharm 214:87–91.
   Web of Science ®Google Scholar
• Göppert TM, Müller RH. (2003). Plasma protein adsorption of Tween 80- and Poloxamer 188-stabilized Solid Lipid nanoparticles. J Drug Target 11:225–31.
   PubMed Web of Science ®Google Scholar
• Guan X, Gao M, Xu H, et al. (2016). Quercetin-loaded poly (lactic-co-glycolic acid)-d-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles for the targeted treatment of liver cancer. Drug Delivery 23:3307–18.
   PubMed Web of Science ®Google Scholar
• Hadinoto K, Sundaresan A, Cheow WS. (2013). Lipid–polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review. Eur J Pharm Biopharm 85:427–43.
   PubMed Web of Science ®Google Scholar
• Hashad RA, Ishak RA, Geneidi AS, Mansour S. (2016). Methotrexate loading in chitosan nanoparticles at a novel pH:Response surface modeling, optimization and characterization. Int J Biol Macromol 91:630–9.
   PubMed Web of Science ®Google Scholar
• Hoosain FG, Choonara YE, Tomar LK, et al. (2015). Bypassing P-glycoprotein drug efflux mechanisms: possible applications in pharmacoresistant schizophrenia therapy. Biomed Res Int 2015:484963.
   PubMed Web of Science ®Google Scholar
• Ishak RA, Mortada ND, Zaki NM, et al. (2014). Impact of microparticle formulation approaches on drug burst release: a level A IVIVC. J Microencapsul 31:674–84.
   PubMed Web of Science ®Google Scholar
• Javed H, Khan M, Ahmad A, et al. (2012). Rutin prevents cognitive impairments by ameliorating oxidative stress and neuroinflammation in rat model of sporadic dementia of Alzheimer type. Neuroscience 210:340–52.
   PubMed Web of Science ®Google Scholar
• Kandel PK, Fernando LP, Ackroyd PC, Christensen KA. (2011). Incorporating functionalized polyethylene glycol lipids into reprecipitated conjugated polymer nanoparticles for bioconjugation and targeted labeling of cells. Nanoscale 3:1037–45.
   PubMed Web of Science ®Google Scholar
• Kasongo K, Jansch M, Müller R, Walker R. (2011). Evaluation of the in vitro differential protein adsorption patterns of didanosine-loaded nanostructured lipid carriers (NLCs) for potential targeting to the brain. J Liposome Res 21:245–54.
   PubMed Web of Science ®Google Scholar
• Koziara JM, Lockman PR, Allen DD, Mumper RJ. (2003). In situ blood brain barrier transport of nanoparticles. Pharm Res 20:1772–8.
   PubMed Web of Science ®Google Scholar
• Krewson CF, Naghski J. (1952). Some Physical Properties of Rutin. J Am Pharm Assoc 41:582–7.
   Google Scholar
• Kuntić V, Pejić N, Ivković B, et al. (2007). Isocratic RP-HPLC method for rutin determination in solid oral dosage forms. J Pharm Biomed Anal 43:718–21.
   PubMed Web of Science ®Google Scholar
• Lamprecht A, Benoit JP. (2006). Etoposide nanocarriers suppress glioma cell growth by intracellular drug delivery and simultaneous P-glycoprotein inhibition. J Control Release 112:208–13.
   PubMed Web of Science ®Google Scholar
• Manach C, Scalbert A, Morand C, et al. (2004). Polyphenols: food sources and bioavailability. Am J Clin Nutr 79:727–47.
   PubMed Web of Science ®Google Scholar
• Maurer N, Fenske DB, Cullis PR. (2001). Developments in liposomal drug delivery systems. Expert Opin Biol Ther 1:923–47.
   PubMed Web of Science ®Google Scholar
• Meng X, Liu J, Yu X, et al. (2017). Pluronic F127 and D-α-tocopheryl polyethylene glycol succinate (TPGS) mixed micelles for targeting drug delivery across the blood brain barrier. Sci Rep 7:2964. doi:10.1038/s41598-017-03123-y.
   PubMed Web of Science ®Google Scholar
• Mohamed M, Veeranarayanan S, Baliyan A, et al. (2014). Structurally distinct hybrid polymer/lipid nanoconstructs harboring a type-I ribotoxin as cellular imaging and glioblastoma-directed therapeutic vectors. Macromol Biosci 14:1696–711.
   PubMed Web of Science ®Google Scholar
• Moreira P, Siedlak S, Wang X, et al. (2007). Increased autophagic degradation of mitochondria in Alzheimer disease. Autophagy 3:614–5.
   PubMed Web of Science ®Google Scholar
• Mostafa NM. (2017). Comparative analysis of rutin content in some Egyptian plants: a validated RP-HPLC-DAD approach. Eur J Med Plants 19:1–8.
   Google Scholar
• Mourtas S, Michanetzis GPA, Missirlis YF, Antimisiaris SG. (2009). Haemolytic activity of liposomes: effect of vesicle size, lipid concentration and polyethylene glycol-lipid or arsonolipid incorporation. J Biomed Nanotechnol 5:1–7.
   PubMed Web of Science ®Google Scholar
• Mu L, Feng SS. (2003). A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS. J Control Release 86:33–48.
   PubMed Web of Science ®Google Scholar
• Omar S, Scott C, Hamlin A, Obied H. (2017). The protective role of plant biophenols in mechanisms of Alzheimer's disease. J Nutr Biochem 47:1–20.
   PubMed Web of Science ®Google Scholar
• Peer D, Karp JM, Hong S, et al. (2007). Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2:751–60.
   PubMed Web of Science ®Google Scholar
• Pooja D, Kulhari H, Singh MK, et al. (2014). Dendrimer–TPGS mixed micelles for enhanced solubility and cellular toxicity of taxanes. Colloids Surf B: Biointerfaces 121:461–8.
   PubMed Web of Science ®Google Scholar
• Pu F, Mishima K, Irie K, et al. (2007). Neuroprotective effects of quercetin and rutin on spatial memory impairment in an 8-arm radial maze task and neuronal death induced by repeated cerebral ischemia in rats. J Pharmacol Sci 104:329–34.
   PubMed Web of Science ®Google Scholar
• Sailor MJ, Park JH. (2012). Hybrid nanoparticles for detection and treatment of cancer. Adv Mater Weinheim 24:3779–802.
   PubMed Web of Science ®Google Scholar
• Salama H, Mahmoud A, Kamel A, et al. (2012a). Brain delivery of olanzapine by intranasal administration of transfersomal vesicles. J Liposome Res 22:336–45.
   PubMed Web of Science ®Google Scholar
• Salama H, Mahmoud A, Kamel A, et al. (2012b). Phospholipid based colloidal poloxamer-nanocubic vesicles for brain targeting via the nasal route. Colloids Surf B Biointerfaces 100:146–54.
   PubMed Web of Science ®Google Scholar
• Salomone S, Caraci F, Leggio G, et al. (2012). New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs. Br J Clin Pharmacol 73:504–17.
   PubMed Web of Science ®Google Scholar
• Salunkhe SS, Bhatia NM, Kawade VS, Bhatia MS. (2015). Development of lipid based nanoparticulate drug delivery systems and drug carrier complexes for delivery to brain. J Appl Pharm Sci 5:110–29.
   Google Scholar
• Sheng Y, Liu C, Yuan Y, et al. (2009). Long circulating polymeric nanoparticles bearing a combinatorial coating of PEG and water-soluble chitosan. Biomaterials 30:2340–8.
   PubMed Web of Science ®Google Scholar
• Shi K, Zhou J, Zhang Q, et al. (2015). Arginine-glycine-aspartic acid-modified lipid-polymer hybrid nanoparticles for docetaxel delivery in glioblastoma multiforme. J Biomed Nanotechnol 11:382–91.
   PubMed Web of Science ®Google Scholar
• Sri KV, Kondaiah A, Ratna JV, Annapurna A. (2007). Preparation and characterization of quercetin and rutin cyclodextrin inclusion complexes. Drug Dev Ind Pharm 33:245–53.
   PubMed Web of Science ®Google Scholar
• Torchilin VP. (2005). Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 4:145–60.
   PubMed Web of Science ®Google Scholar
• Wa Kasongo K. 2010. An investigation into the feasibility of incorporating didanosine into innovative solid lipid nanocarriers. Doctoral PhD Rhodes University.
   Google Scholar
• Wang S, Wang Y, Su Y, et al. (2012). Rutin inhibits beta-amyloid aggregation and cytotoxicity, attenuates oxidative stress, and decreases the production of nitric oxide and proinflammatory cytokines. Neurotoxicology 33:482–90.
   PubMed Web of Science ®Google Scholar
• Yan H, Zhang Z, Jia X, Song J. (2016). D-α-Tocopheryl polyethylene glycol succinate/Solutol HS 15 mixed micelles for the delivery of baohuoside I against non-small-cell lung cancer: optimization and in vitro, in vivo evaluation. IJN 11:4563–71.
   Web of Science ®Google Scholar
• Yang YY, Chung TS, Bai XL, Chan WK. (2000). Effect of preparation conditions on morphology and release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion method. Chem Eng Sci 55:2223–36.
   Web of Science ®Google Scholar
• Yi Y, Li Y, Wu H, et al. (2014). Single-step assembly of polymer-lipid hybrid nanoparticles for mitomycin C delivery. Nanoscale Res Lett 9:1–14.
   PubMed Web of Science ®Google Scholar
• Young KJ, Bennett JP, Zhu X, et al. (2010). The mitochondrial secret(ase) of Alzheimer's disease. JAD 20:S381–S400.
   Web of Science ®Google Scholar
• Zastre JA, Jackson JK, Wong W, Burt HM. (2008). P-Glycoprotein efflux inhibition by amphiphilic diblock copolymers: relationship between copolymer concentration and substrate hydrophobicity. Mol Pharmaceutics 5:643–53.
   PubMed Web of Science ®Google Scholar
• Zhang L, Chan JM, Gu FX, et al. (2008). Self-assembled lipid-polymer hybrid nanoparticles: a robust drug delivery platform. ACS Nano 2:1696–702.
   PubMed Web of Science ®Google Scholar
• Zhang X, Song J, Shi X, et al. (2013). Absorption and metabolism characteristics of rutin in Caco-2 cells. The ScientificWorldJournal 2013:1., 8.
   Google Scholar
• Zhang Z, Tan S, Feng SS. (2012). Vitamin E TPGS as a molecular biomaterial for drug delivery. Biomaterials 33:4889–906.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Yu B, Weecharangsan W, et al. (2010). Transferrin conjugated lipid-coated PLGA nanoparticles for targeted delivery of aromatase inhibitor 7a-APTADD to breast cancer cells. Int J Pharm 390:234–41.
   PubMed Web of Science ®Google Scholar
• Zhu Y-P. 1998. Chinese materia medica: chemistry, pharmacology and applications. Boca Raton, (FL): CRC Press.
   Google Scholar